Buscopan or glucagon for endoscopic cannulation of ampulla of vater?
The number of intravenous injections of hyoscine-N-butylbromide (Buscopan) or glucagon required to maintain relaxation of the duodenum during endoscopic retrograde cholangiopancreatography (ERCP) were compared in a double blind trial of 55 patients. There was no significant difference in the number of injections. Serum amylase levels after the use of both relaxants were compared in 50 patients undergoing ERCP. No significant difference in the levels of hyperamylasaemia were found.
D014670:Ampulla of Vater / Q000187:drug effects*; D000681:Amylases / Q000097:blood; D002086:Butylscopolammonium Bromide / Q000494:pharmacology*; D002760:Cholangiopancreatography, Endoscopic Retrograde; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005934:Glucagon / Q000494:pharmacology*; D006801:Humans; D012602:Scopolamine Derivatives / Q000494:pharmacology*
D012602:Scopolamine Derivatives; D002086:Butylscopolammonium Bromide; D005934:Glucagon; D000681:Amylases